U.S. Markets closed

Rite Aid Corporation (RAD)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
2.54-0.09 (-3.42%)
At close: 4:00PM EDT

2.53 -0.01 (-0.39%)
After hours: 7:56PM EDT

People also watch
Full screen
Previous Close2.63
Bid0.00 x
Ask0.00 x
Day's Range2.48 - 2.62
52 Week Range2.21 - 8.77
Avg. Volume34,756,996
Market Cap2.68B
PE Ratio (TTM)-39.69
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend Date1999-10-14
1y Target EstN/A
Trade prices are not sourced from all markets
  • Moody's7 hours ago

    ReadyCap Commercial Mortgage Trust 2014-1 -- Moody's Affirms Five Classes of RCCMT 2014-1

    Rating Action: Moody's Affirms Five Classes of RCCMT 2014-1. Global Credit Research- 20 Jul 2017. Approximately $76.9 Million of Structured Securities Affected.

  • American City Business Journalsyesterday

    Fred's names new exec to C-suite

    Fred’s Inc. — the pharmacy and general merchandise retailer that recently saw its plans of becoming the third-largest drugstore chain in the U.S. shattered — announced July 19 that Jason Jenne was appointed executive vice president and CFO of Fred’s, effective immediately. Jenne replaces Rick Hans in the position. Hans joined Fred’s in April 2016 under then-Fred’s CEO Jerry A. Shore.

  • Rite Aid Corporation (RAD) Stock Will Never Be the Same Again

    Rite Aid Corporation (RAD) Stock Will Never Be the Same Again

    The Rite Aid that will emerge from the WBA deal will be much different than the company that existed before the deal. Walgreens was going to buy RAD for $9.4 billion, or about $9 per share. The Federal Trade Commission (FTC) didn’t like that idea, so it told Walgreens and Rite Aid to go back to the drawing board.